Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia

Becker, Esther B. E., Zuliani, Luigi, Pettingill, Rosemary, Lang, Bethan, Waters, Patrick, Dulneva, Anna, Sobott, Frank, Wardle, Mark, Graus, Francesc, Bataller, Luis, Robertson, Neil ORCID: https://orcid.org/0000-0002-5409-4909 and Vincent, Angela 2012. Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia. Journal of Neurology, Neurosurgery & Psychiatry 83 (4) , pp. 437-440. 10.1136/jnnp-2011-301506

Full text not available from this repository.

Abstract

Background Relatively few studies have searched for potentially pathogenic antibodies in non-paraneoplastic patients with cerebellar ataxia. Methods and Results We first screened sera from 52 idiopathic ataxia patients for binding of serum IgG antibodies to cerebellar neurons. One strong-binding serum was selected for immunoprecipitation and mass spectrometry, which resulted in the identification of contactin-associated protein 2 (CASPR2) as a major antigen. CASPR2 antibodies were then found by a cell-based assay in 9/88 (10%) ataxia patients, compared to 3/144 (2%) multiple sclerosis or dementia controls (p=0.011). CASPR2 is strongly expressed in the cerebellum, only partly in association with voltage-gated potassium channels. Conclusions Prospective studies are now needed to see whether identification of CASPR2 antibodies has relevance for the diagnosis and treatment of idiopathic cerebellar ataxia.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Research Institutes & Centres > MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG) Schools > Medicine
Subjects:	R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
Publisher:	BMJ Publishing Group
ISSN:	0022-3050
Last Modified:	24 Oct 2022 09:55
URI:	https://orca.cardiff.ac.uk/id/eprint/42578

Citation Data

Cited 96 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item